Shear-Wave elastography for the estimation of liver fibrosis in chronic liver disease: Determining accuracy and ideal site for measurement

Anthony E. Samir, Manish Dhyani, Abhinav Vij, Atul K. Bhan, Elkan F. Halpern, Jorge Méndez-Navarro, Kathleen E. Corey, Raymond T. Chung

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Purpose: To evaluate the accuracy of shear-wave elastography (SWE) for staging liver fibrosis in patients with diffuse liver disease (including patients with hepatitis C virus [HCV]) and to determine the relative accuracy of SWE measurements obtained from different hepatic acquisition sites for staging liver fibrosis. Materials and Methods: The institutional review board approved this single-institution prospective study, which was performed between January 2010 and March 2013 in 136 consecutive patients who underwent SWE before their scheduled liver biopsy (age range, 18-76 years; mean age, 49 years; 70 men, 66 women). Informed consent was obtained from all patients. SWE measurements were obtained at four sites in the liver. Biopsy specimens were reviewed in a blinded manner by a pathologist using METAVIR criteria. SWE measurements and biopsy results were compared by using the Spearman correlation and receiver operating characteristic (ROC) curve analysis. Results: SWE values obtained at the upper right lobe showed the highest correlation with estimation of fibrosis (r = 0.41, P < .001). Inflammation and steatosis did not show any correlation with SWE values except for values from the left lobe, which showed correlation with steatosis (r = 0.24, P = .004). The area under the ROC curve (AUC) in the differentiation of stage F2 fibrosis or greater, stage F3 fibrosis or greater, and stage F4 fibrosis was 0.77 (95% confidence interval [CI]: 0.68, 0.86), 0.82 (95% CI: 0.75, 0.91), and 0.82 (95% CI: 0.70, 0.95), respectively, for all subjects who underwent liver biopsy. The corresponding AUCs for the subset of patients with HCV were 0.80 (95% CI: 0.67, 0.92), 0.82 (95% CI: 0.70, 0.95), and 0.89 (95% CI: 0.73, 1.00). The adjusted AUCs for differentiating stage F2 or greater fibrosis in patients with chronic liver disease and those with HCV were 0.84 and 0.87, respectively. Conclusion: SWE estimates of liver stiffness obtained from the right upper lobe showed the best correlation with liver fibrosis severity and can potentially be used as a noninvasive test to differentiate intermediate degrees of liver fibrosis in patients with liver disease.

Original languageEnglish (US)
Pages (from-to)888-896
Number of pages9
JournalRadiology
Volume274
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Elasticity Imaging Techniques
Liver Cirrhosis
Liver Diseases
Chronic Disease
Confidence Intervals
Fibrosis
Hepacivirus
Liver
Biopsy
ROC Curve
Area Under Curve
Research Ethics Committees
Informed Consent
Prospective Studies
Inflammation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Shear-Wave elastography for the estimation of liver fibrosis in chronic liver disease : Determining accuracy and ideal site for measurement. / Samir, Anthony E.; Dhyani, Manish; Vij, Abhinav; Bhan, Atul K.; Halpern, Elkan F.; Méndez-Navarro, Jorge; Corey, Kathleen E.; Chung, Raymond T.

In: Radiology, Vol. 274, No. 3, 01.03.2015, p. 888-896.

Research output: Contribution to journalArticle

Samir, Anthony E. ; Dhyani, Manish ; Vij, Abhinav ; Bhan, Atul K. ; Halpern, Elkan F. ; Méndez-Navarro, Jorge ; Corey, Kathleen E. ; Chung, Raymond T. / Shear-Wave elastography for the estimation of liver fibrosis in chronic liver disease : Determining accuracy and ideal site for measurement. In: Radiology. 2015 ; Vol. 274, No. 3. pp. 888-896.
@article{cce34b0403fd4a549a182003ddae4502,
title = "Shear-Wave elastography for the estimation of liver fibrosis in chronic liver disease: Determining accuracy and ideal site for measurement",
abstract = "Purpose: To evaluate the accuracy of shear-wave elastography (SWE) for staging liver fibrosis in patients with diffuse liver disease (including patients with hepatitis C virus [HCV]) and to determine the relative accuracy of SWE measurements obtained from different hepatic acquisition sites for staging liver fibrosis. Materials and Methods: The institutional review board approved this single-institution prospective study, which was performed between January 2010 and March 2013 in 136 consecutive patients who underwent SWE before their scheduled liver biopsy (age range, 18-76 years; mean age, 49 years; 70 men, 66 women). Informed consent was obtained from all patients. SWE measurements were obtained at four sites in the liver. Biopsy specimens were reviewed in a blinded manner by a pathologist using METAVIR criteria. SWE measurements and biopsy results were compared by using the Spearman correlation and receiver operating characteristic (ROC) curve analysis. Results: SWE values obtained at the upper right lobe showed the highest correlation with estimation of fibrosis (r = 0.41, P < .001). Inflammation and steatosis did not show any correlation with SWE values except for values from the left lobe, which showed correlation with steatosis (r = 0.24, P = .004). The area under the ROC curve (AUC) in the differentiation of stage F2 fibrosis or greater, stage F3 fibrosis or greater, and stage F4 fibrosis was 0.77 (95{\%} confidence interval [CI]: 0.68, 0.86), 0.82 (95{\%} CI: 0.75, 0.91), and 0.82 (95{\%} CI: 0.70, 0.95), respectively, for all subjects who underwent liver biopsy. The corresponding AUCs for the subset of patients with HCV were 0.80 (95{\%} CI: 0.67, 0.92), 0.82 (95{\%} CI: 0.70, 0.95), and 0.89 (95{\%} CI: 0.73, 1.00). The adjusted AUCs for differentiating stage F2 or greater fibrosis in patients with chronic liver disease and those with HCV were 0.84 and 0.87, respectively. Conclusion: SWE estimates of liver stiffness obtained from the right upper lobe showed the best correlation with liver fibrosis severity and can potentially be used as a noninvasive test to differentiate intermediate degrees of liver fibrosis in patients with liver disease.",
author = "Samir, {Anthony E.} and Manish Dhyani and Abhinav Vij and Bhan, {Atul K.} and Halpern, {Elkan F.} and Jorge M{\'e}ndez-Navarro and Corey, {Kathleen E.} and Chung, {Raymond T.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1148/radiol.14140839",
language = "English (US)",
volume = "274",
pages = "888--896",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Shear-Wave elastography for the estimation of liver fibrosis in chronic liver disease

T2 - Determining accuracy and ideal site for measurement

AU - Samir, Anthony E.

AU - Dhyani, Manish

AU - Vij, Abhinav

AU - Bhan, Atul K.

AU - Halpern, Elkan F.

AU - Méndez-Navarro, Jorge

AU - Corey, Kathleen E.

AU - Chung, Raymond T.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Purpose: To evaluate the accuracy of shear-wave elastography (SWE) for staging liver fibrosis in patients with diffuse liver disease (including patients with hepatitis C virus [HCV]) and to determine the relative accuracy of SWE measurements obtained from different hepatic acquisition sites for staging liver fibrosis. Materials and Methods: The institutional review board approved this single-institution prospective study, which was performed between January 2010 and March 2013 in 136 consecutive patients who underwent SWE before their scheduled liver biopsy (age range, 18-76 years; mean age, 49 years; 70 men, 66 women). Informed consent was obtained from all patients. SWE measurements were obtained at four sites in the liver. Biopsy specimens were reviewed in a blinded manner by a pathologist using METAVIR criteria. SWE measurements and biopsy results were compared by using the Spearman correlation and receiver operating characteristic (ROC) curve analysis. Results: SWE values obtained at the upper right lobe showed the highest correlation with estimation of fibrosis (r = 0.41, P < .001). Inflammation and steatosis did not show any correlation with SWE values except for values from the left lobe, which showed correlation with steatosis (r = 0.24, P = .004). The area under the ROC curve (AUC) in the differentiation of stage F2 fibrosis or greater, stage F3 fibrosis or greater, and stage F4 fibrosis was 0.77 (95% confidence interval [CI]: 0.68, 0.86), 0.82 (95% CI: 0.75, 0.91), and 0.82 (95% CI: 0.70, 0.95), respectively, for all subjects who underwent liver biopsy. The corresponding AUCs for the subset of patients with HCV were 0.80 (95% CI: 0.67, 0.92), 0.82 (95% CI: 0.70, 0.95), and 0.89 (95% CI: 0.73, 1.00). The adjusted AUCs for differentiating stage F2 or greater fibrosis in patients with chronic liver disease and those with HCV were 0.84 and 0.87, respectively. Conclusion: SWE estimates of liver stiffness obtained from the right upper lobe showed the best correlation with liver fibrosis severity and can potentially be used as a noninvasive test to differentiate intermediate degrees of liver fibrosis in patients with liver disease.

AB - Purpose: To evaluate the accuracy of shear-wave elastography (SWE) for staging liver fibrosis in patients with diffuse liver disease (including patients with hepatitis C virus [HCV]) and to determine the relative accuracy of SWE measurements obtained from different hepatic acquisition sites for staging liver fibrosis. Materials and Methods: The institutional review board approved this single-institution prospective study, which was performed between January 2010 and March 2013 in 136 consecutive patients who underwent SWE before their scheduled liver biopsy (age range, 18-76 years; mean age, 49 years; 70 men, 66 women). Informed consent was obtained from all patients. SWE measurements were obtained at four sites in the liver. Biopsy specimens were reviewed in a blinded manner by a pathologist using METAVIR criteria. SWE measurements and biopsy results were compared by using the Spearman correlation and receiver operating characteristic (ROC) curve analysis. Results: SWE values obtained at the upper right lobe showed the highest correlation with estimation of fibrosis (r = 0.41, P < .001). Inflammation and steatosis did not show any correlation with SWE values except for values from the left lobe, which showed correlation with steatosis (r = 0.24, P = .004). The area under the ROC curve (AUC) in the differentiation of stage F2 fibrosis or greater, stage F3 fibrosis or greater, and stage F4 fibrosis was 0.77 (95% confidence interval [CI]: 0.68, 0.86), 0.82 (95% CI: 0.75, 0.91), and 0.82 (95% CI: 0.70, 0.95), respectively, for all subjects who underwent liver biopsy. The corresponding AUCs for the subset of patients with HCV were 0.80 (95% CI: 0.67, 0.92), 0.82 (95% CI: 0.70, 0.95), and 0.89 (95% CI: 0.73, 1.00). The adjusted AUCs for differentiating stage F2 or greater fibrosis in patients with chronic liver disease and those with HCV were 0.84 and 0.87, respectively. Conclusion: SWE estimates of liver stiffness obtained from the right upper lobe showed the best correlation with liver fibrosis severity and can potentially be used as a noninvasive test to differentiate intermediate degrees of liver fibrosis in patients with liver disease.

UR - http://www.scopus.com/inward/record.url?scp=84924303289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924303289&partnerID=8YFLogxK

U2 - 10.1148/radiol.14140839

DO - 10.1148/radiol.14140839

M3 - Article

C2 - 25393946

AN - SCOPUS:84924303289

VL - 274

SP - 888

EP - 896

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -